Cargando…
12-item version of Boston Naming Test: usefulness in the diagnosis of primary progressive aphasia, frontotemporal dementia, and Alzheimer's disease
The 12-item version of the Boston Naming Test (BNT) was adapted to Argentina for the detection of dementia due to Alzheimer's disease (AD), with scores similar to the original 60-item version (sensitivity and specificity of 85 and 94%, respectively) without demographic influence (age and educat...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academia Brasileira de Neurologia, Departamento de Neurologia Cognitiva e Envelhecimento
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173795/ https://www.ncbi.nlm.nih.gov/pubmed/35720650 http://dx.doi.org/10.1590/1980-5764-DN-2021-0043 |
_version_ | 1784722097106321408 |
---|---|
author | Graviotto, Héctor Gastón Sorbara, Marcos German Rodriguez, Carlos Mario Turizo Serrano, Cecilia |
author_facet | Graviotto, Héctor Gastón Sorbara, Marcos German Rodriguez, Carlos Mario Turizo Serrano, Cecilia |
author_sort | Graviotto, Héctor Gastón |
collection | PubMed |
description | The 12-item version of the Boston Naming Test (BNT) was adapted to Argentina for the detection of dementia due to Alzheimer's disease (AD), with scores similar to the original 60-item version (sensitivity and specificity of 85 and 94%, respectively) without demographic influence (age and educational level). To date, no publications on the use of abbreviated BNT in other degenerative pathologies with language impairment have been reported. OBJECTIVE: The objective of this study was to evaluate the usefulness of 12-item BNT in primary progressive aphasia (PPA), the behavioral variant of frontotemporal dementia (FTDbv), and AD. METHODS: Notably, 47 patients with probable AD (NIA-AA 2011) — clinical dementia rating (CDR) 0.5–1, 55 with FTDbv, 17 with PPA, and 46 controls were evaluated and matched for age and education. Exclusion criteria were as follows: alcoholism, other previous neurological or psychiatric illnesses, and education <4 years. All were assessed with a full neuropsychological battery and a 12-item version of BNT. RESULTS: Median scores of 12-item BNT were as follows: PPA: 3.87 (SD=2.99), AD: 6.13 (SD=3.03); FTDbv: 8.41 (SD=2.53); and controls: 10.22 (SD=1.82). Receiver Operating Characteristic (ROC) curves were plotted. CONCLUSIONS: The 12-item version of BNT can be useful, simple, and fast to identify and differentiate PPA, FTDbv, and AD from controls while retaining the discriminative ability of the original version. |
format | Online Article Text |
id | pubmed-9173795 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Academia Brasileira de Neurologia, Departamento de Neurologia Cognitiva e Envelhecimento |
record_format | MEDLINE/PubMed |
spelling | pubmed-91737952022-06-17 12-item version of Boston Naming Test: usefulness in the diagnosis of primary progressive aphasia, frontotemporal dementia, and Alzheimer's disease Graviotto, Héctor Gastón Sorbara, Marcos German Rodriguez, Carlos Mario Turizo Serrano, Cecilia Dement Neuropsychol Original Article The 12-item version of the Boston Naming Test (BNT) was adapted to Argentina for the detection of dementia due to Alzheimer's disease (AD), with scores similar to the original 60-item version (sensitivity and specificity of 85 and 94%, respectively) without demographic influence (age and educational level). To date, no publications on the use of abbreviated BNT in other degenerative pathologies with language impairment have been reported. OBJECTIVE: The objective of this study was to evaluate the usefulness of 12-item BNT in primary progressive aphasia (PPA), the behavioral variant of frontotemporal dementia (FTDbv), and AD. METHODS: Notably, 47 patients with probable AD (NIA-AA 2011) — clinical dementia rating (CDR) 0.5–1, 55 with FTDbv, 17 with PPA, and 46 controls were evaluated and matched for age and education. Exclusion criteria were as follows: alcoholism, other previous neurological or psychiatric illnesses, and education <4 years. All were assessed with a full neuropsychological battery and a 12-item version of BNT. RESULTS: Median scores of 12-item BNT were as follows: PPA: 3.87 (SD=2.99), AD: 6.13 (SD=3.03); FTDbv: 8.41 (SD=2.53); and controls: 10.22 (SD=1.82). Receiver Operating Characteristic (ROC) curves were plotted. CONCLUSIONS: The 12-item version of BNT can be useful, simple, and fast to identify and differentiate PPA, FTDbv, and AD from controls while retaining the discriminative ability of the original version. Academia Brasileira de Neurologia, Departamento de Neurologia Cognitiva e Envelhecimento 2022-04-29 2022 /pmc/articles/PMC9173795/ /pubmed/35720650 http://dx.doi.org/10.1590/1980-5764-DN-2021-0043 Text en https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License |
spellingShingle | Original Article Graviotto, Héctor Gastón Sorbara, Marcos German Rodriguez, Carlos Mario Turizo Serrano, Cecilia 12-item version of Boston Naming Test: usefulness in the diagnosis of primary progressive aphasia, frontotemporal dementia, and Alzheimer's disease |
title | 12-item version of Boston Naming Test: usefulness in the diagnosis of primary progressive aphasia, frontotemporal dementia, and Alzheimer's disease |
title_full | 12-item version of Boston Naming Test: usefulness in the diagnosis of primary progressive aphasia, frontotemporal dementia, and Alzheimer's disease |
title_fullStr | 12-item version of Boston Naming Test: usefulness in the diagnosis of primary progressive aphasia, frontotemporal dementia, and Alzheimer's disease |
title_full_unstemmed | 12-item version of Boston Naming Test: usefulness in the diagnosis of primary progressive aphasia, frontotemporal dementia, and Alzheimer's disease |
title_short | 12-item version of Boston Naming Test: usefulness in the diagnosis of primary progressive aphasia, frontotemporal dementia, and Alzheimer's disease |
title_sort | 12-item version of boston naming test: usefulness in the diagnosis of primary progressive aphasia, frontotemporal dementia, and alzheimer's disease |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173795/ https://www.ncbi.nlm.nih.gov/pubmed/35720650 http://dx.doi.org/10.1590/1980-5764-DN-2021-0043 |
work_keys_str_mv | AT graviottohectorgaston 12itemversionofbostonnamingtestusefulnessinthediagnosisofprimaryprogressiveaphasiafrontotemporaldementiaandalzheimersdisease AT sorbaramarcosgerman 12itemversionofbostonnamingtestusefulnessinthediagnosisofprimaryprogressiveaphasiafrontotemporaldementiaandalzheimersdisease AT rodriguezcarlosmarioturizo 12itemversionofbostonnamingtestusefulnessinthediagnosisofprimaryprogressiveaphasiafrontotemporaldementiaandalzheimersdisease AT serranocecilia 12itemversionofbostonnamingtestusefulnessinthediagnosisofprimaryprogressiveaphasiafrontotemporaldementiaandalzheimersdisease |